nodes	percent_of_prediction	percent_of_DWPC	metapath
Dexfenfluramine—CYP1A2—Carmustine—malignant glioma	0.376	1	CbGbCtD
Dexfenfluramine—HTR2C—choroid plexus—malignant glioma	0.0865	0.404	CbGeAlD
Dexfenfluramine—HTR2C—telencephalic ventricle—malignant glioma	0.0253	0.118	CbGeAlD
Dexfenfluramine—HTR2C—brainstem—malignant glioma	0.00686	0.032	CbGeAlD
Dexfenfluramine—SLC6A4—brainstem—malignant glioma	0.0065	0.0303	CbGeAlD
Dexfenfluramine—HTR2C—telencephalon—malignant glioma	0.00609	0.0284	CbGeAlD
Dexfenfluramine—SLC6A4—telencephalon—malignant glioma	0.00577	0.0269	CbGeAlD
Dexfenfluramine—HTR2B—telencephalon—malignant glioma	0.00572	0.0267	CbGeAlD
Dexfenfluramine—HTR2C—medulla oblongata—malignant glioma	0.00478	0.0223	CbGeAlD
Dexfenfluramine—HTR2C—midbrain—malignant glioma	0.00437	0.0204	CbGeAlD
Dexfenfluramine—HTR2C—spinal cord—malignant glioma	0.00426	0.0199	CbGeAlD
Dexfenfluramine—SLC6A4—midbrain—malignant glioma	0.00414	0.0193	CbGeAlD
Dexfenfluramine—CYP2A6—cerebellum—malignant glioma	0.00413	0.0193	CbGeAlD
Dexfenfluramine—SLC6A4—spinal cord—malignant glioma	0.00404	0.0189	CbGeAlD
Dexfenfluramine—CYP2E1—telencephalon—malignant glioma	0.00351	0.0164	CbGeAlD
Dexfenfluramine—HTR2C—central nervous system—malignant glioma	0.00346	0.0161	CbGeAlD
Dexfenfluramine—CYP2A6—brain—malignant glioma	0.00335	0.0156	CbGeAlD
Dexfenfluramine—SLC6A4—central nervous system—malignant glioma	0.00328	0.0153	CbGeAlD
Dexfenfluramine—HTR2B—central nervous system—malignant glioma	0.00325	0.0152	CbGeAlD
Dexfenfluramine—CYP2D6—brainstem—malignant glioma	0.00313	0.0146	CbGeAlD
Dexfenfluramine—CYP2D6—telencephalon—malignant glioma	0.00278	0.013	CbGeAlD
Dexfenfluramine—CYP2E1—medulla oblongata—malignant glioma	0.00276	0.0129	CbGeAlD
Dexfenfluramine—HTR2C—brain—malignant glioma	0.00275	0.0128	CbGeAlD
Dexfenfluramine—SLC6A4—brain—malignant glioma	0.0026	0.0121	CbGeAlD
Dexfenfluramine—HTR2B—brain—malignant glioma	0.00258	0.012	CbGeAlD
Dexfenfluramine—CYP2E1—spinal cord—malignant glioma	0.00246	0.0115	CbGeAlD
Dexfenfluramine—CYP2E1—central nervous system—malignant glioma	0.002	0.00931	CbGeAlD
Dexfenfluramine—CYP2E1—cerebellum—malignant glioma	0.00195	0.0091	CbGeAlD
Dexfenfluramine—CYP2E1—brain—malignant glioma	0.00159	0.00739	CbGeAlD
Dexfenfluramine—CYP2D6—central nervous system—malignant glioma	0.00158	0.00737	CbGeAlD
Dexfenfluramine—CYP2D6—cerebellum—malignant glioma	0.00155	0.00721	CbGeAlD
Dexfenfluramine—CYP2D6—brain—malignant glioma	0.00126	0.00585	CbGeAlD
Dexfenfluramine—HTR2B—Signaling Pathways—MMP3—malignant glioma	9.8e-05	0.000239	CbGpPWpGaD
Dexfenfluramine—HTR2B—GPCR downstream signaling—PIK3CB—malignant glioma	9.77e-05	0.000238	CbGpPWpGaD
Dexfenfluramine—HTR2C—Signaling by GPCR—F2—malignant glioma	9.76e-05	0.000238	CbGpPWpGaD
Dexfenfluramine—HTR2B—Signaling Pathways—CDKN2B—malignant glioma	9.71e-05	0.000237	CbGpPWpGaD
Dexfenfluramine—CYP2C19—Metabolism—CYP2C18—malignant glioma	9.66e-05	0.000236	CbGpPWpGaD
Dexfenfluramine—CYP2E1—Metabolism—PTGS1—malignant glioma	9.49e-05	0.000231	CbGpPWpGaD
Dexfenfluramine—HTR2B—Signaling Pathways—PTK2—malignant glioma	9.43e-05	0.00023	CbGpPWpGaD
Dexfenfluramine—HTR2C—GPCR downstream signaling—AKT2—malignant glioma	9.41e-05	0.00023	CbGpPWpGaD
Dexfenfluramine—HTR2B—GPCR downstream signaling—CXCL8—malignant glioma	9.39e-05	0.000229	CbGpPWpGaD
Dexfenfluramine—CYP2D6—Metabolism—IDH1—malignant glioma	9.37e-05	0.000229	CbGpPWpGaD
Dexfenfluramine—HTR2C—Signaling by GPCR—PIK3CG—malignant glioma	9.34e-05	0.000228	CbGpPWpGaD
Dexfenfluramine—CYP2C9—Metabolism—IDH1—malignant glioma	9.29e-05	0.000227	CbGpPWpGaD
Dexfenfluramine—HTR2B—Signaling Pathways—HES1—malignant glioma	9.27e-05	0.000226	CbGpPWpGaD
Dexfenfluramine—CYP1A2—Metabolism—IDH2—malignant glioma	9.23e-05	0.000225	CbGpPWpGaD
Dexfenfluramine—HTR2B—Signaling Pathways—NCOR1—malignant glioma	9.21e-05	0.000225	CbGpPWpGaD
Dexfenfluramine—HTR2C—Signaling by GPCR—PTPN11—malignant glioma	9.18e-05	0.000224	CbGpPWpGaD
Dexfenfluramine—HTR2C—Signaling Pathways—NOTCH2—malignant glioma	9.12e-05	0.000222	CbGpPWpGaD
Dexfenfluramine—CYP2C19—Metabolism of lipids and lipoproteins—CAV1—malignant glioma	9.11e-05	0.000222	CbGpPWpGaD
Dexfenfluramine—HTR2B—Signaling by GPCR—RAF1—malignant glioma	9.09e-05	0.000222	CbGpPWpGaD
Dexfenfluramine—CYP2D6—Metabolism—SPHK1—malignant glioma	9.07e-05	0.000221	CbGpPWpGaD
Dexfenfluramine—HTR2C—GPCR downstream signaling—PIK3CD—malignant glioma	9.05e-05	0.000221	CbGpPWpGaD
Dexfenfluramine—CYP2C9—Metabolism—SPHK1—malignant glioma	8.99e-05	0.000219	CbGpPWpGaD
Dexfenfluramine—HTR2B—GPCR downstream signaling—IL2—malignant glioma	8.97e-05	0.000219	CbGpPWpGaD
Dexfenfluramine—HTR2C—Signaling Pathways—KNG1—malignant glioma	8.92e-05	0.000218	CbGpPWpGaD
Dexfenfluramine—CYP2D6—Metabolism—CYP2C18—malignant glioma	8.88e-05	0.000217	CbGpPWpGaD
Dexfenfluramine—CYP2A6—Metabolism—GSTP1—malignant glioma	8.88e-05	0.000217	CbGpPWpGaD
Dexfenfluramine—HTR2B—Signaling by GPCR—PIK3CB—malignant glioma	8.87e-05	0.000216	CbGpPWpGaD
Dexfenfluramine—HTR2B—Signaling Pathways—PDGFRA—malignant glioma	8.82e-05	0.000215	CbGpPWpGaD
Dexfenfluramine—CYP2E1—Metabolism—BCHE—malignant glioma	8.82e-05	0.000215	CbGpPWpGaD
Dexfenfluramine—CYP2C9—Metabolism—CYP2C18—malignant glioma	8.81e-05	0.000215	CbGpPWpGaD
Dexfenfluramine—CYP2E1—Metabolism—SLC5A5—malignant glioma	8.71e-05	0.000213	CbGpPWpGaD
Dexfenfluramine—CYP1A2—Metabolism of lipids and lipoproteins—NCOR1—malignant glioma	8.71e-05	0.000212	CbGpPWpGaD
Dexfenfluramine—CYP1A2—Metabolism—CYP2B6—malignant glioma	8.68e-05	0.000212	CbGpPWpGaD
Dexfenfluramine—CYP2A6—Metabolism—CAT—malignant glioma	8.64e-05	0.000211	CbGpPWpGaD
Dexfenfluramine—HTR2B—Signaling Pathways—SPP1—malignant glioma	8.57e-05	0.000209	CbGpPWpGaD
Dexfenfluramine—HTR2C—Signaling by GPCR—AKT2—malignant glioma	8.55e-05	0.000209	CbGpPWpGaD
Dexfenfluramine—HTR2B—Signaling by GPCR—CXCL8—malignant glioma	8.53e-05	0.000208	CbGpPWpGaD
Dexfenfluramine—HTR2C—Signaling Pathways—NTRK1—malignant glioma	8.5e-05	0.000207	CbGpPWpGaD
Dexfenfluramine—CYP2C9—Metabolism of lipids and lipoproteins—CAV1—malignant glioma	8.3e-05	0.000203	CbGpPWpGaD
Dexfenfluramine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CG—malignant glioma	8.3e-05	0.000202	CbGpPWpGaD
Dexfenfluramine—HTR2C—Signaling by GPCR—PIK3CD—malignant glioma	8.21e-05	0.0002	CbGpPWpGaD
Dexfenfluramine—CYP2A6—Metabolism—NCOR1—malignant glioma	8.16e-05	0.000199	CbGpPWpGaD
Dexfenfluramine—HTR2B—Signaling by GPCR—IL2—malignant glioma	8.15e-05	0.000199	CbGpPWpGaD
Dexfenfluramine—HTR2B—Signaling Pathways—TERT—malignant glioma	8.12e-05	0.000198	CbGpPWpGaD
Dexfenfluramine—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—malignant glioma	8.01e-05	0.000195	CbGpPWpGaD
Dexfenfluramine—CYP1A2—Metabolism—IDH1—malignant glioma	7.94e-05	0.000194	CbGpPWpGaD
Dexfenfluramine—HTR2B—Signaling Pathways—PDGFB—malignant glioma	7.93e-05	0.000193	CbGpPWpGaD
Dexfenfluramine—HTR2C—Signaling Pathways—MMP3—malignant glioma	7.91e-05	0.000193	CbGpPWpGaD
Dexfenfluramine—HTR2B—Signaling Pathways—FGFR1—malignant glioma	7.88e-05	0.000192	CbGpPWpGaD
Dexfenfluramine—HTR2C—GPCR downstream signaling—PIK3CB—malignant glioma	7.88e-05	0.000192	CbGpPWpGaD
Dexfenfluramine—HTR2C—Signaling Pathways—CDKN2B—malignant glioma	7.84e-05	0.000191	CbGpPWpGaD
Dexfenfluramine—CYP2C19—Metabolism—GSTT1—malignant glioma	7.81e-05	0.000191	CbGpPWpGaD
Dexfenfluramine—HTR2B—Signaling Pathways—HIF1A—malignant glioma	7.77e-05	0.000189	CbGpPWpGaD
Dexfenfluramine—CYP1A2—Metabolism—SPHK1—malignant glioma	7.68e-05	0.000187	CbGpPWpGaD
Dexfenfluramine—HTR2C—Signaling Pathways—PTK2—malignant glioma	7.61e-05	0.000186	CbGpPWpGaD
Dexfenfluramine—HTR2C—GPCR downstream signaling—CXCL8—malignant glioma	7.58e-05	0.000185	CbGpPWpGaD
Dexfenfluramine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—malignant glioma	7.56e-05	0.000185	CbGpPWpGaD
Dexfenfluramine—CYP1A2—Metabolism—CYP2C18—malignant glioma	7.53e-05	0.000184	CbGpPWpGaD
Dexfenfluramine—HTR2B—Signaling Pathways—CAV1—malignant glioma	7.51e-05	0.000183	CbGpPWpGaD
Dexfenfluramine—HTR2C—Signaling Pathways—HES1—malignant glioma	7.48e-05	0.000182	CbGpPWpGaD
Dexfenfluramine—HTR2C—Signaling Pathways—NCOR1—malignant glioma	7.43e-05	0.000181	CbGpPWpGaD
Dexfenfluramine—HTR2B—Signaling Pathways—KDR—malignant glioma	7.43e-05	0.000181	CbGpPWpGaD
Dexfenfluramine—HTR2C—Signaling by GPCR—RAF1—malignant glioma	7.33e-05	0.000179	CbGpPWpGaD
Dexfenfluramine—CYP2C19—Metabolism—PTGS1—malignant glioma	7.32e-05	0.000179	CbGpPWpGaD
Dexfenfluramine—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—malignant glioma	7.3e-05	0.000178	CbGpPWpGaD
Dexfenfluramine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CD—malignant glioma	7.29e-05	0.000178	CbGpPWpGaD
Dexfenfluramine—HTR2C—GPCR downstream signaling—IL2—malignant glioma	7.24e-05	0.000177	CbGpPWpGaD
Dexfenfluramine—CYP2D6—Metabolism—GSTT1—malignant glioma	7.18e-05	0.000175	CbGpPWpGaD
Dexfenfluramine—HTR2C—Signaling by GPCR—PIK3CB—malignant glioma	7.16e-05	0.000175	CbGpPWpGaD
Dexfenfluramine—HTR2B—Signaling Pathways—FN1—malignant glioma	7.15e-05	0.000174	CbGpPWpGaD
Dexfenfluramine—HTR2B—Signaling Pathways—F2—malignant glioma	7.15e-05	0.000174	CbGpPWpGaD
Dexfenfluramine—CYP2C9—Metabolism—GSTT1—malignant glioma	7.12e-05	0.000174	CbGpPWpGaD
Dexfenfluramine—HTR2C—Signaling Pathways—PDGFRA—malignant glioma	7.12e-05	0.000174	CbGpPWpGaD
Dexfenfluramine—CYP1A2—Metabolism of lipids and lipoproteins—CAV1—malignant glioma	7.1e-05	0.000173	CbGpPWpGaD
Dexfenfluramine—HTR2B—Signaling Pathways—BAD—malignant glioma	7.06e-05	0.000172	CbGpPWpGaD
Dexfenfluramine—CYP2E1—Metabolism—GSTP1—malignant glioma	7.02e-05	0.000171	CbGpPWpGaD
Dexfenfluramine—HTR2B—Signaling Pathways—NOTCH1—malignant glioma	7e-05	0.000171	CbGpPWpGaD
Dexfenfluramine—HTR2C—Signaling Pathways—SPP1—malignant glioma	6.91e-05	0.000169	CbGpPWpGaD
Dexfenfluramine—HTR2C—Signaling by GPCR—CXCL8—malignant glioma	6.88e-05	0.000168	CbGpPWpGaD
Dexfenfluramine—HTR2B—Signaling Pathways—CD80—malignant glioma	6.85e-05	0.000167	CbGpPWpGaD
Dexfenfluramine—HTR2B—Signaling Pathways—APC—malignant glioma	6.84e-05	0.000167	CbGpPWpGaD
Dexfenfluramine—HTR2B—Signaling Pathways—PIK3CG—malignant glioma	6.84e-05	0.000167	CbGpPWpGaD
Dexfenfluramine—CYP2E1—Metabolism—CAT—malignant glioma	6.83e-05	0.000167	CbGpPWpGaD
Dexfenfluramine—CYP2C19—Metabolism—BCHE—malignant glioma	6.81e-05	0.000166	CbGpPWpGaD
Dexfenfluramine—HTR2B—Signaling Pathways—EGF—malignant glioma	6.76e-05	0.000165	CbGpPWpGaD
Dexfenfluramine—CYP2D6—Metabolism—PTGS1—malignant glioma	6.73e-05	0.000164	CbGpPWpGaD
Dexfenfluramine—CYP2C19—Metabolism—SLC5A5—malignant glioma	6.72e-05	0.000164	CbGpPWpGaD
Dexfenfluramine—HTR2B—Signaling Pathways—PTPN11—malignant glioma	6.72e-05	0.000164	CbGpPWpGaD
Dexfenfluramine—CYP2C9—Metabolism—PTGS1—malignant glioma	6.67e-05	0.000163	CbGpPWpGaD
Dexfenfluramine—CYP2A6—Metabolism—CAV1—malignant glioma	6.65e-05	0.000162	CbGpPWpGaD
Dexfenfluramine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—malignant glioma	6.65e-05	0.000162	CbGpPWpGaD
Dexfenfluramine—HTR2C—Signaling by GPCR—IL2—malignant glioma	6.58e-05	0.00016	CbGpPWpGaD
Dexfenfluramine—HTR2C—Signaling Pathways—TERT—malignant glioma	6.55e-05	0.00016	CbGpPWpGaD
Dexfenfluramine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—malignant glioma	6.46e-05	0.000158	CbGpPWpGaD
Dexfenfluramine—CYP2E1—Metabolism—NCOR1—malignant glioma	6.45e-05	0.000157	CbGpPWpGaD
Dexfenfluramine—HTR2B—Signaling Pathways—BRAF—malignant glioma	6.43e-05	0.000157	CbGpPWpGaD
Dexfenfluramine—HTR2C—Signaling Pathways—PDGFB—malignant glioma	6.39e-05	0.000156	CbGpPWpGaD
Dexfenfluramine—HTR2C—Signaling Pathways—FGFR1—malignant glioma	6.36e-05	0.000155	CbGpPWpGaD
Dexfenfluramine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CB—malignant glioma	6.36e-05	0.000155	CbGpPWpGaD
Dexfenfluramine—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—malignant glioma	6.3e-05	0.000154	CbGpPWpGaD
Dexfenfluramine—HTR2C—Signaling Pathways—HIF1A—malignant glioma	6.27e-05	0.000153	CbGpPWpGaD
Dexfenfluramine—HTR2B—Signaling Pathways—AKT2—malignant glioma	6.26e-05	0.000153	CbGpPWpGaD
Dexfenfluramine—CYP2D6—Metabolism—BCHE—malignant glioma	6.26e-05	0.000153	CbGpPWpGaD
Dexfenfluramine—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—malignant glioma	6.24e-05	0.000152	CbGpPWpGaD
Dexfenfluramine—HTR2B—Signaling by GPCR—EGFR—malignant glioma	6.23e-05	0.000152	CbGpPWpGaD
Dexfenfluramine—CYP2C9—Metabolism—BCHE—malignant glioma	6.2e-05	0.000151	CbGpPWpGaD
Dexfenfluramine—CYP2D6—Metabolism—SLC5A5—malignant glioma	6.18e-05	0.000151	CbGpPWpGaD
Dexfenfluramine—CYP2C9—Metabolism—SLC5A5—malignant glioma	6.13e-05	0.000149	CbGpPWpGaD
Dexfenfluramine—CYP1A2—Metabolism—GSTT1—malignant glioma	6.09e-05	0.000148	CbGpPWpGaD
Dexfenfluramine—CYP2A6—Metabolism—PIK3CG—malignant glioma	6.06e-05	0.000148	CbGpPWpGaD
Dexfenfluramine—HTR2C—Signaling Pathways—CAV1—malignant glioma	6.06e-05	0.000148	CbGpPWpGaD
Dexfenfluramine—HTR2B—Signaling Pathways—PIK3CD—malignant glioma	6.01e-05	0.000147	CbGpPWpGaD
Dexfenfluramine—HTR2C—Signaling Pathways—KDR—malignant glioma	5.99e-05	0.000146	CbGpPWpGaD
Dexfenfluramine—HTR2B—GPCR downstream signaling—PIK3CA—malignant glioma	5.96e-05	0.000145	CbGpPWpGaD
Dexfenfluramine—HTR2B—Signaling by GPCR—KRAS—malignant glioma	5.89e-05	0.000144	CbGpPWpGaD
Dexfenfluramine—CYP2A6—Metabolism—PPARG—malignant glioma	5.85e-05	0.000143	CbGpPWpGaD
Dexfenfluramine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—malignant glioma	5.8e-05	0.000141	CbGpPWpGaD
Dexfenfluramine—HTR2C—Signaling Pathways—F2—malignant glioma	5.77e-05	0.000141	CbGpPWpGaD
Dexfenfluramine—HTR2C—Signaling Pathways—FN1—malignant glioma	5.77e-05	0.000141	CbGpPWpGaD
Dexfenfluramine—HTR2B—Signaling Pathways—FGF2—malignant glioma	5.76e-05	0.00014	CbGpPWpGaD
Dexfenfluramine—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—malignant glioma	5.74e-05	0.00014	CbGpPWpGaD
Dexfenfluramine—CYP1A2—Metabolism—PTGS1—malignant glioma	5.7e-05	0.000139	CbGpPWpGaD
Dexfenfluramine—HTR2C—Signaling Pathways—BAD—malignant glioma	5.7e-05	0.000139	CbGpPWpGaD
Dexfenfluramine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CD—malignant glioma	5.68e-05	0.000139	CbGpPWpGaD
Dexfenfluramine—HTR2C—Signaling Pathways—NOTCH1—malignant glioma	5.64e-05	0.000138	CbGpPWpGaD
Dexfenfluramine—HTR2C—Signaling Pathways—CD80—malignant glioma	5.53e-05	0.000135	CbGpPWpGaD
Dexfenfluramine—HTR2C—Signaling Pathways—APC—malignant glioma	5.52e-05	0.000135	CbGpPWpGaD
Dexfenfluramine—HTR2C—Signaling Pathways—PIK3CG—malignant glioma	5.52e-05	0.000135	CbGpPWpGaD
Dexfenfluramine—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—malignant glioma	5.49e-05	0.000134	CbGpPWpGaD
Dexfenfluramine—HTR2C—Signaling Pathways—EGF—malignant glioma	5.46e-05	0.000133	CbGpPWpGaD
Dexfenfluramine—HTR2C—Signaling Pathways—PTPN11—malignant glioma	5.42e-05	0.000132	CbGpPWpGaD
Dexfenfluramine—CYP2C19—Metabolism—GSTP1—malignant glioma	5.41e-05	0.000132	CbGpPWpGaD
Dexfenfluramine—HTR2B—Signaling by GPCR—PIK3CA—malignant glioma	5.41e-05	0.000132	CbGpPWpGaD
Dexfenfluramine—HTR2B—Signaling Pathways—MDM2—malignant glioma	5.39e-05	0.000131	CbGpPWpGaD
Dexfenfluramine—HTR2B—Signaling Pathways—RAF1—malignant glioma	5.37e-05	0.000131	CbGpPWpGaD
Dexfenfluramine—CYP2A6—Metabolism—PIK3CD—malignant glioma	5.33e-05	0.00013	CbGpPWpGaD
Dexfenfluramine—HTR2B—Signaling Pathways—ERBB2—malignant glioma	5.31e-05	0.00013	CbGpPWpGaD
Dexfenfluramine—CYP1A2—Metabolism—BCHE—malignant glioma	5.3e-05	0.000129	CbGpPWpGaD
Dexfenfluramine—CYP2C19—Metabolism—CAT—malignant glioma	5.27e-05	0.000129	CbGpPWpGaD
Dexfenfluramine—CYP2E1—Metabolism—CAV1—malignant glioma	5.26e-05	0.000128	CbGpPWpGaD
Dexfenfluramine—HTR2B—Signaling Pathways—PIK3CB—malignant glioma	5.24e-05	0.000128	CbGpPWpGaD
Dexfenfluramine—CYP1A2—Metabolism—SLC5A5—malignant glioma	5.24e-05	0.000128	CbGpPWpGaD
Dexfenfluramine—HTR2C—Signaling Pathways—BRAF—malignant glioma	5.19e-05	0.000127	CbGpPWpGaD
Dexfenfluramine—HTR2C—Signaling Pathways—AKT2—malignant glioma	5.05e-05	0.000123	CbGpPWpGaD
Dexfenfluramine—HTR2B—Signaling Pathways—CXCL8—malignant glioma	5.04e-05	0.000123	CbGpPWpGaD
Dexfenfluramine—HTR2C—Signaling by GPCR—EGFR—malignant glioma	5.03e-05	0.000123	CbGpPWpGaD
Dexfenfluramine—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—malignant glioma	5.01e-05	0.000122	CbGpPWpGaD
Dexfenfluramine—CYP2D6—Metabolism—GSTP1—malignant glioma	4.98e-05	0.000121	CbGpPWpGaD
Dexfenfluramine—CYP2C19—Metabolism—NCOR1—malignant glioma	4.98e-05	0.000121	CbGpPWpGaD
Dexfenfluramine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—malignant glioma	4.95e-05	0.000121	CbGpPWpGaD
Dexfenfluramine—CYP2C9—Metabolism—GSTP1—malignant glioma	4.94e-05	0.00012	CbGpPWpGaD
Dexfenfluramine—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—malignant glioma	4.91e-05	0.00012	CbGpPWpGaD
Dexfenfluramine—HTR2B—GPCR downstream signaling—AKT1—malignant glioma	4.87e-05	0.000119	CbGpPWpGaD
Dexfenfluramine—HTR2C—Signaling Pathways—PIK3CD—malignant glioma	4.85e-05	0.000118	CbGpPWpGaD
Dexfenfluramine—CYP2D6—Metabolism—CAT—malignant glioma	4.85e-05	0.000118	CbGpPWpGaD
Dexfenfluramine—HTR2B—Signaling Pathways—CASP3—malignant glioma	4.82e-05	0.000118	CbGpPWpGaD
Dexfenfluramine—HTR2B—Signaling Pathways—IL2—malignant glioma	4.81e-05	0.000117	CbGpPWpGaD
Dexfenfluramine—HTR2C—GPCR downstream signaling—PIK3CA—malignant glioma	4.81e-05	0.000117	CbGpPWpGaD
Dexfenfluramine—CYP2C9—Metabolism—CAT—malignant glioma	4.8e-05	0.000117	CbGpPWpGaD
Dexfenfluramine—CYP2E1—Metabolism—PIK3CG—malignant glioma	4.79e-05	0.000117	CbGpPWpGaD
Dexfenfluramine—HTR2C—Signaling by GPCR—KRAS—malignant glioma	4.75e-05	0.000116	CbGpPWpGaD
Dexfenfluramine—HTR2C—Signaling Pathways—FGF2—malignant glioma	4.65e-05	0.000113	CbGpPWpGaD
Dexfenfluramine—CYP2A6—Metabolism—PIK3CB—malignant glioma	4.64e-05	0.000113	CbGpPWpGaD
Dexfenfluramine—CYP2E1—Metabolism—PPARG—malignant glioma	4.62e-05	0.000113	CbGpPWpGaD
Dexfenfluramine—CYP2A6—Metabolism—PTGS2—malignant glioma	4.6e-05	0.000112	CbGpPWpGaD
Dexfenfluramine—CYP2D6—Metabolism—NCOR1—malignant glioma	4.58e-05	0.000112	CbGpPWpGaD
Dexfenfluramine—HTR2B—Signaling Pathways—MMP9—malignant glioma	4.56e-05	0.000111	CbGpPWpGaD
Dexfenfluramine—CYP2C9—Metabolism—NCOR1—malignant glioma	4.54e-05	0.000111	CbGpPWpGaD
Dexfenfluramine—HTR2B—Signaling Pathways—PTEN—malignant glioma	4.53e-05	0.00011	CbGpPWpGaD
Dexfenfluramine—HTR2B—Signaling by GPCR—AKT1—malignant glioma	4.42e-05	0.000108	CbGpPWpGaD
Dexfenfluramine—HTR2C—Signaling by GPCR—PIK3CA—malignant glioma	4.36e-05	0.000106	CbGpPWpGaD
Dexfenfluramine—HTR2C—Signaling Pathways—MDM2—malignant glioma	4.35e-05	0.000106	CbGpPWpGaD
Dexfenfluramine—HTR2C—Signaling Pathways—RAF1—malignant glioma	4.33e-05	0.000106	CbGpPWpGaD
Dexfenfluramine—HTR2C—Signaling Pathways—ERBB2—malignant glioma	4.29e-05	0.000105	CbGpPWpGaD
Dexfenfluramine—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—malignant glioma	4.28e-05	0.000104	CbGpPWpGaD
Dexfenfluramine—HTR2C—Signaling Pathways—PIK3CB—malignant glioma	4.23e-05	0.000103	CbGpPWpGaD
Dexfenfluramine—CYP1A2—Metabolism—GSTP1—malignant glioma	4.22e-05	0.000103	CbGpPWpGaD
Dexfenfluramine—CYP2E1—Metabolism—PIK3CD—malignant glioma	4.21e-05	0.000103	CbGpPWpGaD
Dexfenfluramine—CYP1A2—Metabolism—CAT—malignant glioma	4.11e-05	0.0001	CbGpPWpGaD
Dexfenfluramine—HTR2B—Signaling Pathways—VEGFA—malignant glioma	4.09e-05	9.98e-05	CbGpPWpGaD
Dexfenfluramine—HTR2C—Signaling Pathways—CXCL8—malignant glioma	4.06e-05	9.91e-05	CbGpPWpGaD
Dexfenfluramine—CYP2C19—Metabolism—CAV1—malignant glioma	4.06e-05	9.89e-05	CbGpPWpGaD
Dexfenfluramine—HTR2B—Signaling Pathways—STAT3—malignant glioma	4.05e-05	9.88e-05	CbGpPWpGaD
Dexfenfluramine—CYP2A6—Metabolism—PTEN—malignant glioma	4.01e-05	9.79e-05	CbGpPWpGaD
Dexfenfluramine—HTR2C—GPCR downstream signaling—AKT1—malignant glioma	3.93e-05	9.58e-05	CbGpPWpGaD
Dexfenfluramine—HTR2C—Signaling Pathways—CASP3—malignant glioma	3.89e-05	9.49e-05	CbGpPWpGaD
Dexfenfluramine—HTR2C—Signaling Pathways—IL2—malignant glioma	3.88e-05	9.47e-05	CbGpPWpGaD
Dexfenfluramine—CYP1A2—Metabolism—NCOR1—malignant glioma	3.88e-05	9.46e-05	CbGpPWpGaD
Dexfenfluramine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	3.88e-05	9.45e-05	CbGpPWpGaD
Dexfenfluramine—HTR2B—Signaling Pathways—MYC—malignant glioma	3.76e-05	9.18e-05	CbGpPWpGaD
Dexfenfluramine—CYP2D6—Metabolism—CAV1—malignant glioma	3.73e-05	9.1e-05	CbGpPWpGaD
Dexfenfluramine—CYP2C9—Metabolism—CAV1—malignant glioma	3.7e-05	9.02e-05	CbGpPWpGaD
Dexfenfluramine—CYP2C19—Metabolism—PIK3CG—malignant glioma	3.69e-05	9.01e-05	CbGpPWpGaD
Dexfenfluramine—HTR2B—Signaling Pathways—EGFR—malignant glioma	3.68e-05	8.98e-05	CbGpPWpGaD
Dexfenfluramine—HTR2C—Signaling Pathways—MMP9—malignant glioma	3.68e-05	8.97e-05	CbGpPWpGaD
Dexfenfluramine—CYP2E1—Metabolism—PIK3CB—malignant glioma	3.67e-05	8.95e-05	CbGpPWpGaD
Dexfenfluramine—HTR2C—Signaling Pathways—PTEN—malignant glioma	3.65e-05	8.91e-05	CbGpPWpGaD
Dexfenfluramine—CYP2E1—Metabolism—PTGS2—malignant glioma	3.64e-05	8.87e-05	CbGpPWpGaD
Dexfenfluramine—CYP2C19—Metabolism—PPARG—malignant glioma	3.57e-05	8.7e-05	CbGpPWpGaD
Dexfenfluramine—HTR2C—Signaling by GPCR—AKT1—malignant glioma	3.57e-05	8.7e-05	CbGpPWpGaD
Dexfenfluramine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	3.53e-05	8.62e-05	CbGpPWpGaD
Dexfenfluramine—HTR2B—Signaling Pathways—KRAS—malignant glioma	3.48e-05	8.48e-05	CbGpPWpGaD
Dexfenfluramine—CYP2D6—Metabolism—PIK3CG—malignant glioma	3.4e-05	8.29e-05	CbGpPWpGaD
Dexfenfluramine—CYP2C9—Metabolism—PIK3CG—malignant glioma	3.37e-05	8.22e-05	CbGpPWpGaD
Dexfenfluramine—HTR2C—Signaling Pathways—VEGFA—malignant glioma	3.3e-05	8.05e-05	CbGpPWpGaD
Dexfenfluramine—CYP2D6—Metabolism—PPARG—malignant glioma	3.28e-05	8e-05	CbGpPWpGaD
Dexfenfluramine—HTR2C—Signaling Pathways—STAT3—malignant glioma	3.27e-05	7.97e-05	CbGpPWpGaD
Dexfenfluramine—CYP2C9—Metabolism—PPARG—malignant glioma	3.25e-05	7.93e-05	CbGpPWpGaD
Dexfenfluramine—CYP2C19—Metabolism—PIK3CD—malignant glioma	3.25e-05	7.92e-05	CbGpPWpGaD
Dexfenfluramine—HTR2B—Signaling Pathways—PIK3CA—malignant glioma	3.2e-05	7.79e-05	CbGpPWpGaD
Dexfenfluramine—CYP2E1—Metabolism—PTEN—malignant glioma	3.17e-05	7.73e-05	CbGpPWpGaD
Dexfenfluramine—CYP1A2—Metabolism—CAV1—malignant glioma	3.16e-05	7.71e-05	CbGpPWpGaD
Dexfenfluramine—HTR2B—Signaling Pathways—TP53—malignant glioma	3.09e-05	7.54e-05	CbGpPWpGaD
Dexfenfluramine—HTR2C—Signaling Pathways—MYC—malignant glioma	3.04e-05	7.41e-05	CbGpPWpGaD
Dexfenfluramine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	3.02e-05	7.36e-05	CbGpPWpGaD
Dexfenfluramine—CYP2D6—Metabolism—PIK3CD—malignant glioma	2.99e-05	7.29e-05	CbGpPWpGaD
Dexfenfluramine—HTR2C—Signaling Pathways—EGFR—malignant glioma	2.97e-05	7.25e-05	CbGpPWpGaD
Dexfenfluramine—CYP2C9—Metabolism—PIK3CD—malignant glioma	2.96e-05	7.22e-05	CbGpPWpGaD
Dexfenfluramine—CYP1A2—Metabolism—PIK3CG—malignant glioma	2.88e-05	7.02e-05	CbGpPWpGaD
Dexfenfluramine—CYP2C19—Metabolism—PIK3CB—malignant glioma	2.83e-05	6.91e-05	CbGpPWpGaD
Dexfenfluramine—CYP2A6—Metabolism—PIK3CA—malignant glioma	2.83e-05	6.9e-05	CbGpPWpGaD
Dexfenfluramine—HTR2C—Signaling Pathways—KRAS—malignant glioma	2.81e-05	6.84e-05	CbGpPWpGaD
Dexfenfluramine—CYP2C19—Metabolism—PTGS2—malignant glioma	2.81e-05	6.84e-05	CbGpPWpGaD
Dexfenfluramine—CYP1A2—Metabolism—PPARG—malignant glioma	2.78e-05	6.78e-05	CbGpPWpGaD
Dexfenfluramine—HTR2B—Signaling Pathways—AKT1—malignant glioma	2.61e-05	6.37e-05	CbGpPWpGaD
Dexfenfluramine—CYP2D6—Metabolism—PIK3CB—malignant glioma	2.6e-05	6.35e-05	CbGpPWpGaD
Dexfenfluramine—CYP2C9—Metabolism—PIK3CB—malignant glioma	2.58e-05	6.3e-05	CbGpPWpGaD
Dexfenfluramine—CYP2D6—Metabolism—PTGS2—malignant glioma	2.58e-05	6.29e-05	CbGpPWpGaD
Dexfenfluramine—HTR2C—Signaling Pathways—PIK3CA—malignant glioma	2.58e-05	6.29e-05	CbGpPWpGaD
Dexfenfluramine—CYP2C9—Metabolism—PTGS2—malignant glioma	2.56e-05	6.24e-05	CbGpPWpGaD
Dexfenfluramine—CYP1A2—Metabolism—PIK3CD—malignant glioma	2.53e-05	6.17e-05	CbGpPWpGaD
Dexfenfluramine—HTR2C—Signaling Pathways—TP53—malignant glioma	2.49e-05	6.08e-05	CbGpPWpGaD
Dexfenfluramine—CYP2C19—Metabolism—PTEN—malignant glioma	2.45e-05	5.97e-05	CbGpPWpGaD
Dexfenfluramine—CYP2A6—Metabolism—AKT1—malignant glioma	2.31e-05	5.64e-05	CbGpPWpGaD
Dexfenfluramine—CYP2D6—Metabolism—PTEN—malignant glioma	2.25e-05	5.49e-05	CbGpPWpGaD
Dexfenfluramine—CYP2E1—Metabolism—PIK3CA—malignant glioma	2.24e-05	5.46e-05	CbGpPWpGaD
Dexfenfluramine—CYP2C9—Metabolism—PTEN—malignant glioma	2.23e-05	5.44e-05	CbGpPWpGaD
Dexfenfluramine—CYP1A2—Metabolism—PIK3CB—malignant glioma	2.21e-05	5.38e-05	CbGpPWpGaD
Dexfenfluramine—CYP1A2—Metabolism—PTGS2—malignant glioma	2.19e-05	5.33e-05	CbGpPWpGaD
Dexfenfluramine—HTR2C—Signaling Pathways—AKT1—malignant glioma	2.11e-05	5.14e-05	CbGpPWpGaD
Dexfenfluramine—CYP1A2—Metabolism—PTEN—malignant glioma	1.91e-05	4.65e-05	CbGpPWpGaD
Dexfenfluramine—CYP2E1—Metabolism—AKT1—malignant glioma	1.83e-05	4.46e-05	CbGpPWpGaD
Dexfenfluramine—CYP2C19—Metabolism—PIK3CA—malignant glioma	1.73e-05	4.21e-05	CbGpPWpGaD
Dexfenfluramine—CYP2D6—Metabolism—PIK3CA—malignant glioma	1.59e-05	3.87e-05	CbGpPWpGaD
Dexfenfluramine—CYP2C9—Metabolism—PIK3CA—malignant glioma	1.57e-05	3.84e-05	CbGpPWpGaD
Dexfenfluramine—CYP2C19—Metabolism—AKT1—malignant glioma	1.41e-05	3.44e-05	CbGpPWpGaD
Dexfenfluramine—CYP1A2—Metabolism—PIK3CA—malignant glioma	1.34e-05	3.28e-05	CbGpPWpGaD
Dexfenfluramine—CYP2D6—Metabolism—AKT1—malignant glioma	1.3e-05	3.16e-05	CbGpPWpGaD
Dexfenfluramine—CYP2C9—Metabolism—AKT1—malignant glioma	1.29e-05	3.14e-05	CbGpPWpGaD
Dexfenfluramine—CYP1A2—Metabolism—AKT1—malignant glioma	1.1e-05	2.68e-05	CbGpPWpGaD
